ArticleMaterials today. Bio2023

Nanocarriers of shRNA-Runx2 directed to collagen IV as a nanotherapeutic system to target calcific aortic valve disease.

Geanina Voicu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.